Indoco Remedies lands German health approval for Baddi plant
The German Health Authority cleared Indoco's Baddi Plant III for oral solid dosage production, opening a new route into EU markets.
What's new
- German Health Authority granted EU GMP certification to Indoco's Baddi Plant III.
- The approval follows an inspection of the oral solid dosage facility in April 2026.
- Indoco can now supply products from this site to the European Union.
Why this matters
Regulatory approvals are the lifeblood of pharmaceutical exports. While Indoco already holds USFDA and UK-MHRA clearances, adding German certification for a specific site expands its manufacturing footprint for the EU. It is a clear operational win for a company with a market cap of ₹1,881 crore.
What we're watching
- New supply contracts or product launches specifically tied to this facility.
- Any updates on export volume growth to the EU in upcoming quarters.
- Whether other facilities undergo similar inspections this year.
The full read
Indoco Remedies has secured EU GMP certification for its Baddi Plant III facility. The German Health Authority granted the approval following an inspection of the oral solid dosage site in April 2026.
It is a win.
For a company with a market capitalization of ₹1,881 crore, this is a meaningful expansion of its regulatory reach. While Indoco already holds approvals from the USFDA and UK-MHRA, this certification provides a new, compliant pathway to supply the European Union from this specific plant, validating the site's manufacturing standards and removing a barrier to entry for new product exports. The next test is how quickly Indoco can convert this compliance into new supply agreements for the EU market.
Questions answered
- What does this certification allow Indoco to do?
- The EU GMP certification confirms that the Baddi Plant III facility meets European manufacturing standards. This allows the company to export oral solid dosage products from this specific site to EU markets.
- When was the facility inspected?
- The German Health Authority conducted the inspection of the Baddi Plant III facility in late April 2026.
- Does Indoco have other regulatory approvals?
- Yes. The company already holds certifications from the USFDA and the UK-MHRA, along with prior EU GMP approvals for other manufacturing sites.
- Why is this specific approval important?
- This certification provides new regulatory clearance for a specific manufacturing site, Baddi Plant III. It increases the company's capacity to serve regulated markets in Europe.